Bone mineral metabolism: Recent data and perspectives related to osteogenesis;Ḿtabolisme mińral osseux: Donńes ŕcentes et perspectives relatives ̀ l'ost́ogeǹse

Archives de Pediatrie

Volumn 11, Issue 12, 2004, Pages 1473-1483

  Gennero, I ^a,c   Moulin, P ^b   Edouard, T ^b   Conte Auriol, F ^b,c   Tauber, M T ^b,c   Salles, J P ^b,c  

^a Serv Univ Psychiat l'Enfant l'A   (France)

^b HÔPITAL DES ENFANTS   (France)

^c CHU PURPAN   (France)

Author keywords

Biphosphonate; FGF 23; Fibroblast growth factor 23; Osteogenesis; Osteoporosis; Ost oge se; Ost oporose; Parathyroid hormone; PTH

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; GROWTH HORMONE; OXYGENASE; PARATHYROID HORMONE; FIBROBLAST GROWTH FACTOR; PARATHYROID HORMONE RELATED PROTEIN;

ALBRIGHT SYNDROME; BONE DEVELOPMENT; BONE DISEASE; BONE MINERAL; CALCIUM METABOLISM; GENETIC DISORDER; HUMAN; HYPOPHOSPHATEMIA; METABOLIC REGULATION; MINERAL METABOLISM; PHOSPHATE METABOLISM; REVIEW; VITAMIN D METABOLISM; BONE; CHILD; HOMEOSTASIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

BONE AND BONES; BONE DISEASES; CHILD; FIBROBLAST GROWTH FACTORS; HOMEOSTASIS; HUMANS; OSTEOGENESIS; PARATHYROID HORMONE-RELATED PROTEIN;

EID: 11144248440     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2004.08.006     Document Type: Short Survey

References (54)

1. M.C. De Vernejoul L'os, un domaine qui ́merge Ḿdecine/ sciences 17 2001 1239 1241
2. V. Cormier-Daire, and M. Le Merrer Classification moĺculaire des maladies osseuses constitutionnelles Ḿdecine Th́rapeutique 7 2001 440 444
3. I. Kone Paut, J.M. Gennari, K. Retornaz, J.L. Jouve, and G. Bollini Biphosphonates chez l'enfant: pŕsent et avenir Arch. Pediatr. 9 2002 836 842 Erratum in 2002:; 9:: 1301
4. C.E. Dent Problems in metabolic bone disease B. Frame M. Parfitt H. Duncan Clinical aspects of metabolic bone disease 1973 Exerpta Medica Amsterdam 1 7 ́ds.
5. C.J. Rosen, and J.P. Bilezikian Clinical review 123: Anabolic therapy for osteoporosis J. Clin. Endocrinol. Metab. 86 2001 957 964
6. M. Zaidi, H.C. Blair, B.S. Moonga, E. Abe, and C.L. Huang Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics J. Bone Miner. Res. 18 2003 599 609
7. E.M. Brown, and R.J. MacLeod Extracellular calcium sensing and extracellular calcium signaling Physiol. Rev. 81 2001 239 297
8. W.H. Horl Renal osteodystrophy: Role of calcimimetics Am. J. Kidney Dis. 41 3 Suppl 1 2003 S104 S107
9. H. Juppner, and J.T. Potts Jr. Immunoassays for the detection of parathyroid hormone J. Bone Miner. Res. 17 Suppl 2 2002 N81 N86
10. G. Karsenty Chondrogenesis just ain't what it used to be J. Clin. Invest. 107 2001 405 407
11. E. Schipani, K. Kruse, and H. Jüppner A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia Science 268 1995 98 100
12. P. Zhang, A.S. Jobert, A. Couvineau, and C. Silve A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia J. Clin. Endocrinol. Metab. 83 1998 3365 3368
13. S. Hopyan, N. Gokgoz, R. Poon, R.C. Gensure, C. Yu, and W.G. Cole A mutant PTH/PTHrP type I receptor in enchondromatosis Nat. Genet. 30 2002 6 10
14. M. Hewison, V. Kantorovich, H.R. Liker, A.J. Van Herle, P. Cohan, and D. Zehnder Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages J. Bone Miner. Res. 18 2003 579 582
15. A.F. Stewart Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton J. Bone Miner. Res. 17 2002 758 762
16. Y. Takeuchi, S. Fukumoto, K. Nakayama, Y. Tamura, A. Yanagisawa, and T. Fujita Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for seven years in a patient with malignant islet cell tumor J. Bone Miner. Res. 17 2002 753 757
17. J.T. Swarthout, R.C. D'Alonzo, N. Selvamurugan, and N.C. Partridge Parathyroid hormone-dependent signaling pathways regulating genes in bone cells Gene 282 2002 1 17
18. J.L. Vahle, M. Sato, G.G. Long, J.K. Young, P.C. Francis, and J.A. Engelhardt Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety Toxicol. Pathol. 30 2002 312 321
19. J. Reeve Recombinant human parathyroid hormone BMJ 324 2002 435 436
20. G. Kuijpers, B. Schneider, B. Stadel, and E. Colman Recombinant human parathyroid hormone. Preclinical data on rat osteosarcoma were not dismissed BMJ 324 2002 1398
21. M. Homme, C.P. Schmitt, R. Himmele, G.F. Hoffmann, O. Mehls, and F. Schaefer Vitamin D and dexamethasone inversely regulate parathyroid hormone-induced regulator of G protein signaling-2 expression in osteoblast-like cells Endocrinology 144 2003 2496 2504
22. L.S. Weinstein, S. Yu, D.R. Warner, and J. Liu Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting Endocr. Rev. 22 2001 675 705
23. M.D. Stone, D.J. Hosking, C. Garcia-Himmelstine, D.A. White, D. Rosenblum, and H.G. Worth The renal response to exogenous parathyroid hormone in treated pseudohypoparathryroidism Bone 14 1993 727 735
24. J. Liu, B. Erlichman, and L.S. Weinstein The stimulatory G protein alpha-subunit Gs alpha is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B J. Clin. Endocrinol. Metab. 88 2003 4336 4341
25. E.L. Germain-Lee, J. Groman, J.L. Crane, S.M. Jan de Beur, and M.A. Levine Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance J. Clin. Endocrinol. Metab. 88 2003 4059 4069
26. S.M. Jan De Beur, J.R. O'Connell, R. Peila, J. Cho, Z. Deng, and S. Kam The pseudohypoparathyroidism type lb locus is linked to a region including GNAS1 at 20q13.3 J. Bone Miner. Res. 18 2003 424 433
27. M.C. Eddy, S.M. Jan De Beur, S.M. Yandow, W.H. McAlister, E.M. Shore, and F.S. Kaplan Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification J. Bone Miner. Res. 15 2000 2074 2083
28. G.L. Yeh, S. Mathur, A. Wivel, M. Li, F.H. Gannon, and A. Ulied GNAS1 mutation and Cbfa1 misexpression in a child with severe congenital platelike osteoma cutis J. Bone Miner. Res. 15 2000 2063 2073
29. P. Bianco, M. Riminucci, A. Majolagbe, S.A. Kuznetsov, M.T. Collins, and M.H. Mankani Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone J. Bone Miner. Res. 15 2000 120 128
30. P. Bianco, S.A. Kuznetsov, M. Riminucci, L.W. Fisher, A.M. Spiegel, and P.G. Robey Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gs alpha-mutated skeletal progenitor cells J. Clin. Invest. 101 1998 1737 1744
31. C. Stevens-Simon, J. Stewart, I.I. Nakashima, and M. White Exacerbation of fibrous dysplasia associated with an adolescent pregnancy J. Adolesc. Health 12 1991 403 405
32. M.T. Collins, C. Chebli, J. Jones, H. Kushner, M. Consugar, and P. Rinaldo Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia J. Bone Miner. Res. 16 2001 806 813
33. L. Beck, A.C. Karaplis, N. Amizuka, A.S. Hewson, H. Ozawa, and H.S. Tenenhouse Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities Proc. Natl. Acad. Sci. USA 95 1998 5372 5377
34. D. Prie, V. Huart, N. Bakouh, G. Planelles, O. Dellis, and B. Gerard Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter N. Engl. J. Med. 347 2002 983 991
35. M.J. Econs, and P.T. McEnery Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder J. Clin. Endocrinol. Metab. 82 1997 674 681
36. T.O. Carpenter Oncogenic osteomalacia - a complex dance of factors N. Engl. J. Med. 348 2003 1705 1708
37. K.E. White, K.B. Jonsson, G. Carn, G. Hampson, T.D. Spector, and M. Mannstadt The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting J. Clin. Endocrinol. Metab. 86 2001 497 500
38. K.B. Jonsson, R. Zahradnik, T. Larsson, K.E. White, T. Sugimoto, and Y. Imanishi Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia N. Engl. J. Med 348 2003 1656 1663
39. M. Riminucci, M.T. Collins, N.S. Fedarko, N. Cherman, A. Corsi, and K.E. White FGF 23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting J. Clin. Invest. 112 2003 683 692
40. L.D. Quarles Evidence for a bone-kidney axis regulating phosphate homeostasis J. Clin. Invest. 112 2003 642 646
41. G. Boileau, H.S. Tenenhouse, L. Desgroseillers, and P. Crine Characterization of PHEX endopeptidase catalytic activity: identification of parathyroid-hormone-related peptide107-139 as a substrate and osteocalcin, PPi and phosphate as inhibitors Biochem. J. 355 2001 707 713
42. D. Miao, X. Bai, D. Panda, M. McKee, A. Karaplis, and D. Goltzman Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition Endocrinology 142 2001 926 939
43. T. Nesbitt, M.K. Drezner, and B. Lobaugh Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1 alpha-hydroxylase activity in the hypophosphatemic mouse. Evidence for a generalized defect of vitamin D metabolism J. Clin. Invest. 77 1986 181 187
44. T. Shimada, H. Hasegawa, Y. Yamazaki, T. Muto, R. Hino, and Y. Takeuchi FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis J. Bone Miner. Res. 19 2004 429 435
45. W.L. Miller, and A.A. Portale Vitamin D 1 alpha-hydroxylase Trends Endocrinol. Metab. 11 2000 315 319
46. R. Saint-Arnaud, O. Dardenne, and F.H. Glorieux Étiologie moĺculaire des rachitismes vitaminod́pendants h́ŕ ditaires Ḿdecine/sciences 17 2001 1289 1296
47. P.J. Malloy, J.W. Pike, and D. Feldman The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets Endocr. Rev. 20 1999 156 188
48. M.Y. Zhang, X. Wang, J.T. Wang, N.A. Compagnone, S.H. Mellon, and J.L. Olson Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1alpha-hydroxylase gene expression in the proximal renal tubule Endocrinology 143 2002 587 595
49. B.R. Peterson Augmenting vitamin D to combat genetic disease Chem. Biol. 9 2002 1265 1266
50. F. Rauch, R. Travers, H. Plotkin, and F.H. Glorieux The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta J. Clin. Invest. 110 2002 1293 1299
51. C.B. Langman Improvement of bone in patients with osteogenesis imperfecta treated with pamidronate-lessons from biochemistry J. Clin. Endocrinol. Metab. 88 2003 984 985
52. F. Rauch, H. Plotkin, L. Zeitlin, and F.H. Glorieux Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy J. Bone Miner. Res. 18 2003 610 614
53. M.S. Fewtrell British Paediatric and Adolescent Bone Group. Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls Arch. Dis. Child 88 2003 795 798
54. M.A. Levine Biochemical markers of bone metabolism: application to understanding bone remodeling in children and adolescents J. Pediatr. Endocrinol. Metab. 16 Suppl 3 2003 661 672